2025
影响因子区间
—
平台估算
9%
2025
中国作者发文占比
1969 USD
收费
期刊简介:Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas:Using registries/databases/health records and other non-selected observational datasets to investigate:drug use and treatment outcomesprescription patternsdrug safety signalsadherence to treatment guidelinesbenefit : risk profilescomparative effectivenesseconomic analyses including cost-of-illnessData-driven research methodologies, including the capture, curation, search, sharing, analysis and interpretation of ‘big data’Techniques and approaches to optimise real-world modelling.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs - Real World Outcomes may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.
【译文】药物 - 真实世界结果旨在发表关于使用真实世界数据评估健康结果和为药物、设备和临床实践中的其他干预措施的健康保健决策提供信息的研究和综述。该期刊包括但不限于以下研究领域:使用登记处/数据库/健康记录和其他非选择的观察性数据集来调查:药物使用和治疗结果、处方模式、药物安全性信号、治疗指南的依从性、效益:风险特征、比较有效性、包括疾病负担的经济分析、数据驱动的研究方法,包括‘大数据’的捕获、整理、搜索、共享、分析和解释、优化真实世界建模的技术和方法。此外,可以与文章一起发布额外的数字功能(包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画);这些功能旨在增加期刊内容的可见性、阅读量和教育价值。此外,发表在《药物 - 真实世界结果》上的文章可能附有通俗易懂的摘要,以帮助那些对该领域有一定了解但不是深入了解的读者理解重要的医学进展。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| 中科院分区 | 4区 | 暂无 |